Comparison of postprandial profiles of ghrelin, active GLP-1, and total PYY to meals varying in fat and carbohydrate and their association with hunger and the phases of satiety

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 5, 2013, Pages

  Gibbons, Catherine ^a   Caudwell, Phillipa ^a   Finlayson, Graham ^a   Webb, Dominic Luc ^b   Hellström, Per M ^b   Näslund, Erik ^c   Blundell, John E ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UPPSALA UNIVERSITY   (Sweden)

^c DANDERYD HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; PEPTIDE YY;

ADULT; ARTICLE; CALORIC INTAKE; CARBOHYDRATE ANALYSIS; CARBOHYDRATE INTAKE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FAT CONTENT; FAT INTAKE; FEMALE; FOOD INTAKE; HORMONE BLOOD LEVEL; HUMAN; HUNGER; LIPID DIET; MALE; OBESITY; POSTPRANDIAL STATE; PRIORITY JOURNAL; SATIETY;

ADULT; APPETITE REGULATION; BIOLOGICAL MARKERS; BODY MASS INDEX; CROSS-OVER STUDIES; DIETARY CARBOHYDRATES; DIETARY FATS; ENERGY INTAKE; ENGLAND; FEMALE; GHRELIN; GLUCAGON-LIKE PEPTIDE 1; HUMANS; HUNGER; MALE; MIDDLE AGED; OVERWEIGHT; PEPTIDE YY; POSTPRANDIAL PERIOD; SATIETY RESPONSE;

EID: 84877697300     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-3835     Document Type: Article

References (40)

1. Wren AM, Bloom SR. Gut hormones and appetite control. Gastroenterology. 2007;132:2116-2130.
2. Cummings D, Frayo RS, Marmonier C, Aubert R, Chapelot D. Plasma ghrelin levels and hunger scores in humans initiating meals voluntarily without time-and food-related cues. Am J Physiol Endocrinol Metab. 2004;287:E297-E304.
3. de Graaf C, Blom WAM, Smeets PA, Stafleu A, Hendriks HF. Biomarkers of satiation and satiety. Am J Clin Nutr. 2004;79:946-961.
4. Druce MR, Wren AM, Park AJ, et al. Ghrelin increases food intake in obese as well as lean subjects. Int J Obes (Lond). 2005;14:1130-1136.
5. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS. Apreprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes. 2001;50:1714-1719.
6. 3-36 physiologically inhibits food intake. Nature. 2002;418:650-654.
7. Kojima M, Kangawa K. Ghrelin: structure and function. Physiol Rev. 2005;85:495-522.
8. Kojima M, Hosada H, Date Y, Nakarzato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402:656-660.
9. Nakarzato M, Murakami N, Date Y, et al. A role for ghrelin in the central regulation of feeding. Nature. 2001;409:194-198.
10. Wren AM, Seal LJ, Cohen MA, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab. 2001; 86:5992-5995.
11. Wren AM, Small CJ, Abbott CR, et al. Ghrelin causes hyperphagia and obesity in rats. Diabetes. 2001;50:2540-2547.
12. Monteleone P, Bencivenga R, Longobardi N, Serritella C, Maj M. Differential responses of circulating ghrelin to high-fat or high-carbohydrate meal in healthy women. J Clin Endocrinol Metab. 2003; 88:5510-5514.
13. Tannousdit El Khoury D, Obeid O, Azar S, Hwalla N. Variations in postprandial ghrelin status following ingestion of high-carbohydrate, high-fat, and high-protein meals in males. Ann Nutr Metab. 2006;50:260-269.
14. Callahan H, Cummings D, Pepe M, Breen P, Matthys C, Weigle D. Postprandial suppression of plasma ghrelin level is proportional to ingested caloric load but does not predict intermeal interval in humans. J Clin Endocrinol Metab. 2004;89:1319-1324.
15. Murphy KG, Bloom SR. Gut hormones and the regulation of energy homeostasis. Nature. 2006;444:854-859.
16. Näslund E, Barkeling B, King N, et al. Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men. Int J Obes Relat Metab Disord. 1999;23:304-311.
17. Drucker DJ, Nauck MA. The incretin system: glucagon-like peptide- 1 agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet. 2006;368:1696-1705.
18. Verdich C, Toubro S, Buemann B, Lysgard MJ, Juul HJ, Astrup A. The role of postprandial releases of insulin and incretin in mealinduced satiety-effect of obesity and weight reduction. Int J Obes Relat Metab Disord. 2001;25:1206-1214.
19. Feinle C, Chapman IM, Wishart J, Horowitz M. Plasma glucagonlike peptide-1 (GLP-1) responses to duodenal fat and glucose infusions in lean and obese men. Peptides. 2002;23:1491-1495.
20. Herrmann C, Göke R, Richter G, Fehmann HC, Arnold R, Göke B. Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients. Digestion. 1995; 56:117-126.
21. Batterham R, Cohen M, Ellis S, et al. Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med. 2003;349:941-948.
22. Essah PA, Levy JR, Sistrun SN, Kelly SM, Nestler JE. Effect of macronutrient composition on postprandial peptide YY levels. J Clin Endocrinol Metab. 2007;92:4052-4055.
23. MacIntosh CG, Andrews JM, Jones KL, et al. Effects of age on concentrations of plasma cholecystokinin, glucagon-like peptide 1, and peptide YY and their relation to appetite and pyloric motility. Am J Clin Nutr. 1999;69:999-1006.
24. Pedersen-Bjergaard U, Høt U, Kelbaek H, et al. Influence of meal composition on postprandial peripheral plasma concentrations of vasoactive peptides in man. Scand J Clin Lab Invest. 1996;56:497-503.
25. Kissileff HR, Carretta JC, Geliebter A, Pi-Sunyer FX. Cholecystokinin and stomach distension combine to reduce food intake in humans. Am J Physiol Regul Integr Comp Physiol. 2003;285:R992- R998.
26. Blundell J, Stubbs R. High and low carbohydrate and fat intakes: limits imposed by appetite and palatability and their implications for energy balance. Eur J Clin Nutr. 1999;53:S148-S165.
27. Lawton C, Burley V, Wales J, Blundell J. Dietary fat and appetite control in obese subjects: weak effects on satiation and satiety. Int J Obes (Lond). 1993;17:409-416.
28. Stubbs RJ, Harbron CG, Murgatroyd PR, Prentice A. Covert manipulation of dietary fat and energy density: effect on substrate flux and food intake in men eating ad libitum. Am J Clin Nutr. 1995; 62:316-329.
29. Blundell JE, Macdiarmid JI. Fat as a risk factor for overconsumption: satiation, satiety, and patterns of eating. J Am Diet Assoc. 1997;97:S63-S69.
30. Raben A, Agerholm-Larsen L, Flint A, Holst JJ, Astrup A. Meals with similar energy densities but rich in protein, fat, carbohydrate, or alcohol have different effects on energy expenditure and substrate metabolism but not on appetite and energy intake. Am J Clin Nutr. 2003;77:91-100.
31. Stubbs RJ, Hughes DA, Johnstone AM, et al. The use of visual analogue scales to assess motivation to eat in human subjects: a review of their reliability and validity with an evaluation of new hand-held computerized systems for temporal tracking of appetite ratings. Br J Nutr. 2000;84:405-415.
32. Gibbons C, Caudwell P, Finlayson G, King N, Blundell J. Validation of a new hand-held electronic data capture method for continuous monitoring of subjective appetite sensations. Int J Behav Nutr Phys Act. 2011;8:57-64.
33. 3-36 on food intake in humans. Gastroenterology. 2005;129:1430-1436.
34. Näslund E, Gutniak M, Skogar S, Rossner S, Hellstrom P. Glucagonlike peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese men. Am J Clin Nutr. 1998;68:525-530.
35. Witte AB, Grybäck P, Holst JJ, et a;. Differential effect of PYY1-36 and PYY3-36 on gastric emptying in man. Regul Pept. 2009;158: 57-62.
36. Batterham RL, Heffron H, Kapoor S, et al. Critical role for peptide YY in protein-mediated satiation and body-weight regulation. Cell Metab. 2006;4:223-233.
37. le Roux CW, Welbourn R, Werling M, et al. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg. 2007;246:780-785.
38. Korner J, Bessler M, Cirilo L, et al. Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin. J Clin Endocrinol Metab. 2005;90:359-365.
39. Falkén Y, Hellström PM, Holst JJ, Näslund E. Changes in glucose homeostasis after Roux-en-Y gastric bypass surgery for obesity at day three, two months, and one year after surgery: role of gut peptides. J Clin Endocrinol Metab. 2011;96:2227-2235.
40. Sumithran P, Prendergast LA, Delbridge E, et al. Long-term persistence of hormonal adaptations to weight loss. N Engl J Med. 2011; 365:1597-1604.